Product LaunchAvita has launched advanced dressings and will soon commercialize a proprietary dermal matrix.
Regulatory ApprovalRECELL-GO received FDA approval on May 30th, 2024, with positive feedback from initial cases.
Revenue GrowthThe company has demonstrated that its flagship RECELL platform is generating nice traction, as evidenced by the 29% revenue growth performance.